Glenview Trust »

Halozyme Therapeutics shares owned by Glenview Trust

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Glenview Trust from 13F filings

Historical chart of Glenview Trust investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Glenview Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Glenview Trust

Quarter filed Position value Share count Share price at filing
2025-09-30 $274k 3.7k 73.34